Rudders R A, Dhillon S, Krontiris T G
Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts.
Cancer Res. 1988 Nov 15;48(22):6272-7.
We have prospectively examined 66 consecutive initial diagnostic lymph node biopsies from unselected patients suspected of having malignant lymphoma for clonal immunophenotypic and immunogenotypic markers. By morphological and cell surface phenotypic criteria 52 had non-Hodgkin's lymphoma derived from the B-cell lineage and in these we compared surface immunoglobulin criteria for clonality with immunoglobulin gene rearrangement as detected by JH, C kappa, and C lambda gene probes. We found that the addition of BglII and HindIII double digests to the standard BamHI and EcoRI restriction enzymes made it possible to detect rearrangement in the vast majority of lymphomas and that rearrangement of both JH alleles is the rule. A rearranged heavy and/or light chain gene was detected in 47 of 52 (91%) tumors and the JH probe alone detected rearrangements in 87% of tumors when multiple restriction enzymes were used. In contrast, surface immunoglobulin, the standard clonal marker for monoclonal B-cell malignancy, was either undetectable or did not exhibit light chain restriction in 29 of 52 tumors as detected by flow cytometric analysis. Further, in 24 of these 29 tumor DNAs we could detect an Ig gene rearrangement. In follicular (nodular) lymphoma which often gives ambiguous immunophenotypic results by cell suspension techniques, monoclonal gene rearrangements were detected in 16 of 18 tumor DNAs. Monoclonal surface immunoglobulin was detected in only 8 of 18 of this subset of cases. The 52 tumors were also analyzed for potential oligoclonality. We found that the use of BglII, a restriction enzyme that closely spanned the JH region, increased the sensitivity of detecting rearrangements and facilitated the identification of isotype switch variants. In only a single (1 of 52) tumor DNA were more than two rearranged bands seen with JH, C kappa, and C lambda probes, suggesting a multiclonal origin. Additional cases thought to potentially represent oligoclonality by immunophenotypic criteria proved to be isotype switch variants. We conclude that Ig gene rearrangement is an extremely sensitive method for defining monoclonality in lymphoma cell populations, particularly if multiple restriction enzymes are used, and that the vast majority of the clonal diversity seen in initial diagnostic biopsies is the result of isotypic switch within a given clone rather than true oligoclonality.
我们前瞻性地检测了66例连续的、未经选择的疑似恶性淋巴瘤患者的初次诊断性淋巴结活检标本,以寻找克隆性免疫表型和免疫基因型标志物。根据形态学和细胞表面表型标准,52例为B细胞系来源的非霍奇金淋巴瘤,我们将表面免疫球蛋白的克隆性标准与通过JH、Cκ和Cλ基因探针检测的免疫球蛋白基因重排进行了比较。我们发现,在标准的BamHI和EcoRI限制性内切酶基础上增加BglII和HindIII双酶切,能够在绝大多数淋巴瘤中检测到重排,并且两个JH等位基因的重排是常见的。在52例肿瘤中的47例(91%)检测到重排的重链和/或轻链基因,当使用多种限制性内切酶时,单独的JH探针在87%的肿瘤中检测到重排。相比之下,通过流式细胞术分析,作为单克隆B细胞恶性肿瘤的标准克隆标志物的表面免疫球蛋白,在52例肿瘤中的29例中无法检测到或未表现出轻链限制。此外,在这29例肿瘤DNA中的24例中,我们能够检测到Ig基因重排。在滤泡性(结节性)淋巴瘤中,通过细胞悬液技术往往会给出模糊的免疫表型结果,在18例肿瘤DNA中的16例检测到单克隆基因重排。在该亚组病例的18例中,仅8例检测到单克隆表面免疫球蛋白。我们还对这52例肿瘤进行了潜在寡克隆性分析。我们发现,使用紧密跨越JH区域的限制性内切酶BglII,提高了检测重排的敏感性,并有助于鉴定同种型转换变体。在仅1例(52例中的1例)肿瘤DNA中,使用JH、Cκ和Cλ探针观察到两条以上的重排条带,提示多克隆起源。其他根据免疫表型标准被认为可能代表寡克隆性的病例,经证实为同种型转换变体。我们得出结论,Ig基因重排是定义淋巴瘤细胞群体中单克隆性的一种极其敏感的方法,特别是如果使用多种限制性内切酶,并且在初次诊断活检中看到的绝大多数克隆多样性是给定克隆内同种型转换的结果,而非真正的寡克隆性。